SEC Filing | Synaptics Incorporated

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Shawn Tsai-Shyang

(Last)

(First)

(Middle)

1251 MCKAY DRIVE

(Street)

SAN JOSE

95131

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/24/2017

3. Issuer Name and Ticker or Trading Symbol
SYNAPTICS Inc [ SYNA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	15,266⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	⁽²⁾	01/28/2020	Common Stock	5,780⁽³⁾	35.76	D
Employee Stock Option (Right to Buy)	⁽⁴⁾	10/28/2020	Common Stock	287⁽⁵⁾	46.5	D
Employee Stock Option (Right to Buy)	⁽⁶⁾	01/27/2021	Common Stock	335⁽⁷⁾	60.22	D
Employee Stock Option (Right to Buy)	⁽⁸⁾	04/28/2021	Common Stock	382⁽⁹⁾	61.4	D
Employee Stock Option (Right to Buy)	⁽¹⁰⁾	08/01/2021	Common Stock	431⁽¹¹⁾	78.11	D
Employee Stock Option (Right to Buy)	⁽¹²⁾	10/24/2021	Common Stock	269⁽¹³⁾	62.105	D
Employee Stock Option (Right to Buy)	⁽¹⁴⁾	01/30/2022	Common Stock	296⁽¹⁵⁾	76.81	D
Employee Stock Option (Right to Buy)	⁽¹⁶⁾	04/24/2022	Common Stock	322	85.69	D
Employee Stock Option (Right to Buy)	⁽¹⁷⁾	07/31/2022	Common Stock	322	79.38	D
Employee Stock Option (Right to Buy)	⁽¹⁸⁾	10/23/2022	Common Stock	704	89.29	D
Employee Stock Option (Right to Buy)	⁽¹⁹⁾	01/29/2023	Common Stock	705	73.31	D
Employee Stock Option (Right to Buy)	⁽²⁰⁾	04/29/2023	Common Stock	705	71.55	D
Employee Stock Option (Right to Buy)	⁽²¹⁾	07/29/2023	Common Stock	705	51.95	D

Explanation of Responses:

1. Includes (i) 1,396 shares that were acquired pursuant to the Issuer's employee stock purchase plan; (ii) 4,868 shares that were acquired upon delivery of vested deferred stock units; and (iii) 9,002 shares underlying deferred stock units that are not yet vested and deliverable.

2. 1/3rd of the 23,500 shares subject to the option granted on 1/28/13 vested and became exercisable on 11/12/13 and 1/36th of the shares subject to the option vested and became exercisable on the 12th day of each month thereafter until fully vested on 11/12/15.

3. Does not include 17,720 shares underlying the option that were previously exercised and sold.

4. 1/12th of the 573 shares subject to the option granted on 10/28/13 vested and became exercisable each quarter commencing on 1/28/14 until fully vested on 10/28/16.

5. Does not include 286 shares underlying the option that were previously exercised and sold.

6. 1/12th of the 573 shares subject to the option granted on 1/27/14 vested and became exercisable each quarter commencing on 4/27/14 until fully vested on 1/27/17.

7. Does not include 238 shares underlying the option that were previously exercised and sold.

8. 1/12th of the 573 shares subject to the option granted on 4/28/14 vested and became exercisable each quarter commencing on 7/28/14 until fully vested on 4/28/17.

9. Does not include 191 shares underlying the option that were previously exercised and sold.

10. 1/12th of the 574 shares subject to the option granted on 8/01/14 vested and became exercisable each quarter commencing on 11/01/14 until fully vested on 8/01/17.

11. Does not include 143 shares underlying the option that were previously exercised and sold.

12. 1/12th of the 322 shares subject to the option granted on 10/24/14 vested or shall vest and became or shall become exercisable each quarter commencing on 1/24/15 until fully vested on 10/24/17.

13. Does not include 53 shares underlying the option that were previously exercised and sold.

14. 1/12th of the 322 shares subject to the option granted on 1/30/15 vested or shall vest and became or shall become exercisable each quarter commencing on 4/30/15 until fully vested on 1/30/18.

15. Does not include 26 shares underlying the option that were previously exercised and sold.

16. 1/12th of the 322 shares subject to the option granted on 4/24/15 vested or shall vest and became or shall become exercisable each quarter commencing on 7/24/15 until fully vested on 4/24/18.

17. 1/12th of the 322 shares subject to the option granted on 7/31/15 vested or shall vest and became or shall become exercisable each quarter commencing on 10/31/15 until fully vested on 7/31/18.

18. 1/12th of the 704 shares subject to the option granted on 10/23/15 vested or shall vest and became or shall become exercisable each quarter commencing on 1/23/16 until fully vested on 10/23/18.

19. 1/12th of the 705 shares subject to the option granted on 1/29/16 vested or shall vest and became or shall become exercisable each quarter commencing on 4/29/16 until fully vested on 1/29/19.

20. 1/12th of the 705 shares subject to the option granted on 4/29/16 vested or shall vest and became or shall become exercisable each quarter commencing on 7/29/16 until fully vested on 4/29/19.

21. 1/12th of the 705 shares subject to the option granted on 7/29/16 vested or shall vest and became or shall become exercisable each quarter commencing on 10/29/16 until fully vested on 7/29/19.

Remarks:

The reporting person is the Vice President and General Manager of the PC division. Exhibit List Exhibit 24 - Limited Power of Attorney

	Kermit Nolan, as Attorney-in-Fact	08/02/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS


	Know all by these presents, that the undersigned hereby makes, constitutes and
appoints each of John McFarland, Megha Aggarwal and Kermit Nolan as the
undersigned's true and lawful attorney-in-fact, with full power and authority as
hereinafter described on behalf of and in the name, place and stead of the
undersigned to:

(1)	prepare, execute, acknowledge, deliver and file Forms 3, 4 and 5 (including
any amendments thereto) with respect to the securities of Synaptics
Incorporated, a Delaware corporation (the "Company"), with the United States
Securities and Exchange Commission, any national securities exchanges and the
Company, as considered necessary or advisable under Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations promulgated
thereunder, as amended from time to time (the "Exchange Act");

(2)	seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such release of
information; and

(3)	perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.

The undersigned acknowledges that:

(1)	this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in their discretion on information provided to such
attorney-in-fact without independent verification of such information;

(2)	any documents prepared and/or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney will be in such form and will
contain such information and disclosure as such attorney-in-fact, in his or her
discretion, deems necessary or desirable;

(3)	neither the Company nor such attorney-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirement of the Exchange
Act, (ii) any liability of the undersigned for any failure to comply with such
requirements, or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and

(4)	this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including without limitation the reporting requirements under Section 16 of the
Exchange Act.

	The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, hereby ratifying all that such attorney-in-fact of, for and on
behalf of the undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney.

	This Power of Attorney supersedes any and all previous powers of attorney
executed with regards to the same subject matter as agreed to herein. This Power
of Attorney shall remain in full force and effect until revoked by the
undersigned in a signed writing delivered to such attorney-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 25th day of July 2017.




                                         /s/ Shawn Tsai-Shyang Liu
                                         _________________________________
                                         Signature


                                         Shawn Tsai-Shyang Liu
                                         _________________________________
                                         Print Name

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This website contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business, and can be identified by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements may include words such as "expect," "anticipate," "intend," "believe," "estimate," "plan," "target," "strategy," "continue," "may," "will," "should," variations of such words, or other words and terms of similar meaning. All forward-looking statements reflect our best judgment and are based on several factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Such factors include, but are not limited to, the risks as identified in the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Business" sections of our Annual Report on Form 10-K for our most recent fiscal year, and other risks as identified from time to time in our Securities and Exchange Commission reports. Forward-looking statements are based on information available to us on the date hereof, and we do not have, and expressly disclaim, any obligation to publicly release any updates or any changes in our expectations, or any change in events, conditions, or circumstances on which any forward-looking statement is based. Our actual results and the timing of certain events could differ materially from the forward-looking statements. These forward-looking statements do not reflect the potential impact of any mergers, acquisitions, or other business combinations that had not been completed as of the date of this filing.